• Damborg Bynum posted an update 1 month, 2 weeks ago

    During the last 60 years numerous significant attempts have been made to achieve a widely acceptable terminology and histological grading for laryngeal squamous intraepithelial lesions. While dysplasia was included in the pathology of the uterine cervix already in 1953, the term dysplasia was accepted in laryngeal pathology first after the Toronto Centennial Conference on Laryngeal Cancer in 1974. In 1963 Kleinsasser proposed a three-tier classification, and in 1971 Kambic and Lenart proposed a four-tier classification. Since then, four editions of the World Health Organisation (WHO) classification have been proposed (1978, 1991, 2005 and 2017). Several terms such as squamous intraepithelial neoplasia (SIN) and laryngeal intraepithelial neoplasia (LIN) are now being abandoned and replaced by squamous intraepithelial lesions (SIL). The essential change between the 2005 and 2017 WHO classifications is the attempt to induce a simplification from a four- to a two-tier system. The current WHO classification (2017) thus recommends the use of a two-tier system with reasonably clear histopathological criteria for the two groups low-grade and high-grade dysplasia. Problems with interobserver variability apart, subjectivities and uncertainties remain, but to a lesser degree. Ongoing and additional molecular studies may help to clarify underlying events that will increase our understanding and possibly can facilitate our attempts to obtain an even better classification. The classification needs to be easier for the general pathologist to perform and easier for the clinician to interpret. These two objectives are equally important to provide each patient the best personalised treatment available for squamous intraepithelial lesions.In the original article, the incorrect Open Access License type has been incuded.Patients with myeloproliferative neoplasms (MPNs), a group of rare haematological conditions including polycythaemia vera, essential thrombocythaemia, and myelofibrosis, often experience a range of symptoms which can significantly impact their quality of life (QoL). Although symptom burden is highest in myelofibrosis and high-risk patients, lower-risk patients also report symptoms impacting their daily life and ability to work. In addition to physical symptoms, MPNs affect emotional well-being, with anxiety and depression frequently reported by patients. Despite significant advances in treatment options, such as the introduction of JAK1/JAK2 inhibitors, therapy for MPNs is often palliative; therefore, reduction of symptoms and improvement of QoL should be considered as major treatment goals. One of the main issues impacting MPN treatment is the discord between patient and physician perceptions of symptom burden, treatment goals, and expectations. New technologies, such as app-based reporting, can aid this com patients’ quality of life (QoL). Targeted drugs, such as ruxolitinib, treat MPNs and reduce symptoms, but do not cure the disease. Patients frequently want to play a bigger part in decisions about their treatment. However, physicians and patients often have different views on how well treatments are working and what to expect from the treatment. This can mean that patients feel they are not getting the best treatment for their symptoms. Also, patients may not be able to get some treatments or take part in a trial of a new drug, depending on where they live. This creates feelings of unfairness which can affect their mental health. Addressing all these problems may help improve the QoL for patients with these blood diseases.Urban dust contamination is becoming progressively noticeable, and heavy metals are primary pollutants in urban environments. The contamination of heavy metals in urban dust has been affecting the urban citizens due to their adverse effects on human health, and understanding their effects is a crucial stage for its management. This study is a review of the reports of heavy metal pollution in urban dust of 16 cities in Iran, aimed at determining pollution status and health risk calculation on the nationwide scale, using geo-accumulation index (Igeo), potential ecological risk index (PER), and health risk assessment model. Six toxic elements, namely cadmium, copper, chromium, nickel, lead, and zinc were evaluated in this study. The results presented that the total heavy metal concentrations in the studied cities decreased in the sequences of Zn > Cu > Pb > Ni > Cr > Cd. The average concentrations of Cd, Cu, Ni, Pb, and Zn in the studied cities exceeded the Iran Standard Soil limits for residential areas. The mean levels of studied heavy metals for cities was in the order of Kermanshah > Tehran > Tabriz > Rafsanjan > Hamedan > Isfahan > Mashhad > Ahvaz > Abadan > Kerman > Bushehr > Kashan > Shiraz > Zahedan > Masjed-e-Soleiman > Arak. The Results of Igeo revealed that the pollution levels of Cd, Cu, Pb, Ni, Cr, and Zn in the studied cities ranged from unpolluted to moderate pollution categorizations. The mean potential ecological risk factor (Eir) values were below (Eri  cadmium. The CR ranks of chromium, nickel, and cadmium were less than the maximum permissible level, presented an insignificant carcinogenic risk.Jussiaea repens (L.) leaf ethanol extract (LEE) and its major phyto-compound (MPC) have effects against larvae and adults of dengue, malarial, and filarial vectors. Total larval death rates were recorded from LEE and MPC has significant larval killing activity with LC50/LC90 values of Ae. albopictus, An. stephensi, and Cx. quinquefasciatus that were 118.3/229.9, 116.1/216.8, 114.4/213.5 and 17.7/27.5, 15.6/25.4 and 12.3/21.1 μg/ml, respectively. A best repellent activity was ascertained at 3.057 mg/cm2 concentration of LEE and MPC provided 100% protection upto 240 min against selected human vector mosquitoes (HVMs). The functional groups were confirmed by FT-IR analysis and their presence in ethanol extract and mass spectral analysis 4-piperidineacetic acid, 1-acetyl-5-ethyl-2-[3-(2-hydroxyethyl]-1H-indol-2-yl]-á-methyl-, methyl ester compound was identified in the LEE. Compound C manufacturer The results obtained suggest that J. repens LEE and its MPC were important and responsible for health protection and control of HVMs.